PIR and colorectal carcinoma: In CRC cells, piR-54265 acts as an oncogenic piRNA, and overexpression of piR-54265 activates STAT3 signaling, consequently enhancing the proliferation, metastasis, and chemoresistance of CRC cells (Mai et al., 2018).